Cargando…

The Role of ARL4C in Erlotinib Resistance: Activation of the Jak2/Stat 5/β-Catenin Signaling Pathway

Cancer patients who initially benefit from Erlotinib, a drug targeting EGFR path, eventually develop resistance to the drug. The underlying mechanism is largely unknown. This study investigated the role of ARL4C in Erlotinib resistance development of NSCLC. qRT-PCR and Western blotting were performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Jinrong, Chen, Zeng, Yu, Zongyang, Huang, Tao, Hu, Dan, Su, Ying, He, Zhiyong, Zou, Changyan, Zhang, Lurong, Lin, Xiandong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657464/ https://www.ncbi.nlm.nih.gov/pubmed/33194732 http://dx.doi.org/10.3389/fonc.2020.585292

Ejemplares similares

SNHG8 Promotes the Progression of Epstein–Barr Virus-Associated Gastric Cancer via Sponging miR-512-5p and Targeting TRIM28
por: Zou, Changyan, et al.
Publicado: (2021)

Regulation of Hippo, TGFβ/SMAD, Wnt/β-Catenin, JAK/STAT, and NOTCH by Long Non-Coding RNAs in Pancreatic Cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2021)

Down-regulation of miR-214 reverses erlotinib resistance in non-small-cell lung cancer through up-regulating LHX6 expression
por: Liao, Jinrong, et al.
Publicado: (2017)

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling
por: Wang, Qiang, et al.
Publicado: (2020)

CXCL1 Regulated by miR-302e Is Involved in Cell Viability and Motility of Colorectal Cancer via Inhibiting JAK-STAT Signaling Pathway
por: Chen, Biyin, et al.
Publicado: (2021)

Association of JAK/STAT genetic variants with cutaneous melanoma
por: Gomez, Gabriela Vilas Bôas, et al.
Publicado: (2022)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
por: Bousoik, Emira, et al.
Publicado: (2018)

Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway
por: Chen, Liwen, et al.
Publicado: (2018)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
por: Huang, Bei, et al.
Publicado: (2022)

RNU12 inhibits gastric cancer progression via sponging miR-575 and targeting BLID
por: Wang, Shaoli, et al.
Publicado: (2023)

Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
por: Butzmann, Alexandra, et al.
Publicado: (2022)

LTF Regulates the Immune Microenvironment of Prostate Cancer Through JAK/STAT3 Pathway
por: Zhao, Qi, et al.
Publicado: (2021)

IL-6/JAK/STAT3 Signaling in Breast Cancer Metastasis: Biology and Treatment
por: Manore, Sara G., et al.
Publicado: (2022)

Efficacy and safety of bevacizumab plus erlotinib versus bevacizumab or erlotinib alone in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Shu, et al.
Publicado: (2016)

Targeting TRIM54/Axin1/β-Catenin Axis Prohibits Proliferation and Metastasis in Hepatocellular Carcinoma
por: Zhu, Jinrong, et al.
Publicado: (2021)

FUS-DDIT3 Fusion Oncoprotein Expression Affects JAK-STAT Signaling in Myxoid Liposarcoma
por: Dolatabadi, Soheila, et al.
Publicado: (2022)

The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
por: Olschok, Kathrin, et al.
Publicado: (2023)

Radiotherapy and Erlotinib Combined: Review of the Preclinical and Clinical Evidence
por: Mehta, Vivek K.
Publicado: (2012)

The CK1δ/ϵ-Tip60 Axis Enhances Wnt/β-Catenin Signaling via Regulating β-Catenin Acetylation in Colon Cancer
por: Ning, Jiong, et al.
Publicado: (2022)

The Interaction Between Autophagy and JAK/STAT3 Signaling Pathway in Tumors
por: Xu, Jiangyan, et al.
Publicado: (2022)

Epigenetic Silencing of STAT3-Targeted miR-193a, by Constitutive Activation of JAK/STAT Signaling, Leads to Tumor Progression Through Overexpression of YWHAZ in Gastric Cancer
por: Wei, Kuo-Liang, et al.
Publicado: (2021)

RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway
por: Su, Jian, et al.
Publicado: (2019)

Novel β-Lactamase bla(ARL) in Staphylococcus arlettae
por: Andreis, Sabrina N., et al.
Publicado: (2017)

Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β‐catenin pathway in NSCLC
por: Wang, Jianmin, et al.
Publicado: (2019)

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway
por: Zhang, Peizhi, et al.
Publicado: (2022)

Hsa_circ_0006692 Promotes Lung Cancer Progression via miR-205-5p/CDK19 Axis
por: Liao, Jinrong, et al.
Publicado: (2022)

Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling
por: Akhtar, Sabah, et al.
Publicado: (2019)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

JAK-STAT and feeding
por: Ladyman, Sharon R., et al.
Publicado: (2013)

Mechanisms of mutant β-catenin in endometrial cancer progression
por: Parrish, Molly L., et al.
Publicado: (2022)

STAT3 paradoxically stimulates β-catenin expression but inhibits β-catenin function
por: Ibrahem, Salih, et al.
Publicado: (2014)

ML264 inhibits osteosarcoma growth and metastasis via inhibition of JAK2/STAT3 and WNT/β‐catenin signalling pathways
por: Huang, Hai, et al.
Publicado: (2020)

Hyperactivation of Wnt/β-catenin and Jak/Stat3 pathways in human and zebrafish foetal growth restriction models: Implications for pharmacological rescue
por: Risato, Giovanni, et al.
Publicado: (2022)

Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-small-cell lung cancer: a systematic review and meta-analysis of randomised controlled trials
por: Deng, Wusheng, et al.
Publicado: (2022)

Chronic Stress Activates PlexinA1/VEGFR2-JAK2-STAT3 in Vascular Endothelial Cells to Promote Angiogenesis
por: Lu, YanJie, et al.
Publicado: (2021)

Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin
por: Hu, Xiaoyuan, et al.
Publicado: (2022)

Epirubicin Enhances the Anti-Cancer Effects of Radioactive (125)I Seeds in Hepatocellular Carcinoma via Downregulation of the JAK/STAT1 Pathway
por: Guo, Lei, et al.
Publicado: (2022)

COL5A2 Inhibits the TGF-β and Wnt/β-Catenin Signaling Pathways to Inhibit the Invasion and Metastasis of Osteosarcoma
por: Han, Yan-Long, et al.
Publicado: (2022)

The small GTPases ARL-13 and ARL-3 coordinate intraflagellar transport and ciliogenesis
por: Li, Yujie, et al.
Publicado: (2010)

lncRNA MIAT/HMGB1 Axis Is Involved in Cisplatin Resistance via Regulating IL6-Mediated Activation of the JAK2/STAT3 Pathway in Nasopharyngeal Carcinoma
por: Zhu, Xuewei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9mq9r99i83eh9cmfivt0p2obbf